Cipla (Large Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Cipla Limited |
|||
|
Price: ₹1,472.05 | ||
| 52 Week Low: ₹1,205.85 52 Week High: ₹1,702.05 |
|||
| Market Capital: 1,21,591.49 Crore (Largecap) | |||
| Healthcare -> Drug Manufacturers—General | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Cipla Share Price Target For 2024
- 1.1.1: Cipla Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Cipla Share Price Target For 2025
- 1.2.1: Cipla Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Cipla Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Cipla Brief Company Overview
- 4: Cipla Financial Performance
- 4.0.1: Is Cipla A Good Buy For Long Term?
To predict the Cipla's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Cipla Share Price Target For 2024
The line chart displays the monthly closing prices of Cipla with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Cipla shares in 2024, see the table below.
Cipla Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 1534.85 (+4.26%) | Fibonacci Extension Level 50.00% |
| 2024 Target 2 | 1507.0 (+2.37%) | Price Action: 05 Dec 2024 High |
| 2024 Target 1 | 1491.9 (+1.34%) | Price Action: May 2024 High |
| Current Price | 1472.05 | Cipla's share price as of 20 Dec 2024 |
| Stop Loss 1 | 1461.35 (-0.73%) | Price Action: 12 Dec 2024 High |
| Stop Loss 2 | 1440.0 (-2.18%) | Price Action: 30 Oct 2024 High |
| Stop Loss 3 | 1425.56 (-3.16%) | Fibonacci Retracement Level 98.60% |
Short-Term Technical Outlook
Current Technical Position: Cipla is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹1481.67 serves as the nearest technical reference point.
Historical Returns: 3-month: -11.01% | 6-month: +0.25% | 1-year: +19.12%
Cipla Share Price Target For 2025
The line chart displays the monthly closing prices of Cipla with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Cipla shares in 2025, see the table below.
Cipla Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1862.34 (+26.51%) | Price Action: Chart |
| 2025 Target 2 | 1827.62 (+24.15%) | Price Action: Chart |
| 2025 Target 1 | 1809.52 (+22.92%) | Fibonacci Extension Level 64.90% |
| Current Price | 1472.05 | Cipla's share price as of 20 Dec 2024 |
| Stop Loss 1 | 1340.68 (-8.93%) | Price Action: Feb 2024 Low |
| Stop Loss 2 | 1323.77 (-10.08%) | Price Action: Apr 2024 Low |
| Stop Loss 3 | 1306.17 (-11.27%) | Price Action: May 2024 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Cipla is currently trading at 53.6% of its 52-week range (₹1205.85 - ₹1702.05).
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: +19.12% | 3-year: +60.61% | 5-year: +221.33%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Cipla Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹1,472.05 | ||
| 2024 | ₹1,681.48 | +14.23% | ₹1,706.70 |
| 2025 | ₹1,715.67 | +2.03% | ₹1,741.41 |
| 2026 | ₹1,700.13 | -0.91% | ₹1,799.45 |
| 2027 | ₹1,805.43 | +6.19% | ₹1,911.81 |
| 2028 | ₹2,024.16 | +12.12% | ₹2,054.52 |
| 2029 | ₹2,135.45 | +5.50% | ₹2,167.48 |
| 2030 | ₹2,155.14 | +0.92% | ₹2,187.47 |
| 2031 | ₹2,114.40 | -1.89% | ₹2,248.95 |
| 2032 | ₹2,224.91 | +5.23% | ₹2,362.44 |
| 2033 | ₹2,473.59 | +11.18% | ₹2,510.69 |
| 2034 | ₹2,589.43 | +4.68% | ₹2,628.27 |
| 2035 | ₹2,594.62 | +0.20% | ₹2,633.54 |
| 2036 | ₹2,528.67 | -2.54% | ₹2,702.92 |
| 2037 | ₹2,644.39 | +4.58% | ₹2,816.42 |
| 2038 | ₹2,923.01 | +10.54% | ₹2,966.86 |
| 2039 | ₹2,995.92 | +2.49% | ₹3,040.86 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Cipla Brief Company Overview
Company Overview: Cipla Limited Cipla Limited is a renowned pharmaceutical manufacturer operating globally, including India, the US, and South Africa. Established in 1935, the company has a rich history of innovation and is known for its commitment to healthcare. Key...
Products and Services: Pharmaceutical products, including active pharmaceutical ingredients and formulations Therapeutic areas: cardiovascular, diabetes, HIV, respiratory, oncology, and more Respiratory products, including inhalers and nasal sprays Other products: injectables, biosimilars, liquid paraffin for constipation Reputation: Cipla Limited holds a strong reputation in the pharmaceutical industry. The company is committed to providing high-quality, affordable medicines to its customers.Cipla Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 1,21,591.49 Crore | Market valuation of Cipla's shares. |
| Revenue (TTM) | 26,264.18 Crore | Total revenue generated by Cipla over the past twelve months. |
| Net Income (TTM) | +44,751,101,952.00 | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +23.18% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +17.03% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+5.60% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+15.20% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
1.62 | Company's total debt divided by total shareholder equity. |
| Total Debt | 461.37 Crore | Sum of Cipla's current & long-term financial obligations. |
| Total Cash | 8,708.2 Crore | Total amount of liquid funds available to Cipla. |
| Beta | 0.34 | Beta is less than 1 indicating that the Cipla's price is less volatile than the market. |
Is Cipla A Good Buy For Long Term?
Cipla, a large-cap stock with a market capitalization of ₹1,21,591.49 crore, shows strong financial health. Its ₹4,475.11 crore net profit (17.03% margin) on ₹26,264.18 crore revenue in the last 12 months, coupled with a healthy cash balance of ₹8,708.2 crore and relatively low debt (₹461.37 crore as of Q2 2024-25), paints a positive picture. While recent quarterly growth is moderate (5.6% revenue increase), the impressive 5-year return of 186.60% suggests strong long-term potential. Overall, Cipla is a good buy for long-term investors.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
